Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) 50mg/200mg/25mg*30's | Cipla Generic | GLT

Generic Information: Bictegravir/Emtricitabine/Tenofovir Alafenamide (Cipla, India)

This listing is the Indian generic of the bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg fixed-dose combination, manufactured by Cipla Ltd. Rather than a branded trade name, it is supplied under the generic designation BIC/FTC/TAF. Cipla is one of the world's largest generic pharmaceutical companies and a long-standing supplier of antiretroviral medicines, including the historic introduction of triple ARV therapy to Africa at under a dollar a day. The product is a complete once-daily single-tablet regimen for HIV-1.

What Is This Combination Used For?

This bictegravir/emtricitabine/tenofovir alafenamide combination treats HIV-1 infection in adults, whether they are beginning therapy for the first time or switching from a stable regimen in which they are already virologically suppressed. As a fixed-dose combination it simplifies treatment to one tablet per day, which is widely recognized as improving adherence and, in turn, durable viral suppression.

How Does This Combination Work?

The three components block HIV at two points in its lifecycle. Bictegravir is an integrase strand transfer inhibitor that stops the virus from integrating into human DNA, while emtricitabine and tenofovir alafenamide are nucleoside reverse transcriptase inhibitors that interrupt viral reverse transcription. By hitting two distinct enzymes, the combination creates a high barrier to resistance, and the tenofovir alafenamide form offers better kidney and bone safety than the older tenofovir disoproxil fumarate.

Indications

The combination is indicated for HIV-1 infection in adults with no known resistance to its components, as either initial therapy or a switch for virologically suppressed patients. It is a complete regimen and must not be combined with other antiretrovirals. It does not cure HIV or prevent transmission, so safer-sex measures and specialist follow-up remain necessary.

Dosage

Take one tablet once daily, with or without food, swallowed whole. Kidney function should be checked because the product is not recommended when creatinine clearance is below 30 mL per minute, and severe liver impairment is also a contraindication. Test for hepatitis B before starting, because stopping the combination in a patient coinfected with HBV can provoke a serious hepatitis flare that requires monitoring for several months.

Side Effects

The most common adverse reactions are diarrhea, nausea, and headache. Bictegravir can raise serum creatinine modestly by blocking tubular secretion, without reflecting a true drop in kidney filtration, and bilirubin may rise. The boxed warning concerns post-treatment acute exacerbation of hepatitis B, and rare serious events include lactic acidosis and immune reconstitution syndrome.

Storage

Store the tablets at room temperature in a dry place, in the original container, and out of reach of children. No refrigeration is necessary.

Why Choose the Cipla Generic?

Cipla's generic bictegravir combination offers the same three-drug efficacy at a fraction of the branded price, an advantage that matters for patients funding their own treatment over many years. Cipla's decades of experience in high-volume antiretroviral manufacturing, including WHO-prequalified products for global health programs, make it a trusted source for affordable HIV therapy. GLT helps buyers obtain this India-sourced generic with proper documentation for import.

How to Order

To order the Cipla bictegravir/emtricitabine/tenofovir alafenamide combination through GLT, contact us on WhatsApp at +86 15234153837 or email [email protected]. Let us know the quantity and destination, and we will confirm availability, sourcing, and shipping terms for your region.

FAQ

Is this the same as Biktarvy? This is the Indian generic of Biktarvy, containing the identical active ingredients — bictegravir, emtricitabine, and tenofovir alafenamide — at the same doses, made by Cipla.

Does this product have a brand name? This listing is supplied under the generic designation BIC/FTC/TAF rather than a branded trade name, which is common for Cipla's antiretroviral line.

How is it dosed? One tablet is taken once daily with or without food, as a complete single-tablet regimen for HIV-1.